<?xml version="1.0" encoding="UTF-8"?>
<p class="p">As mentioned above, dietary linseed oil inhibited the development of food allergy with increased amounts of Î±-linolenic acid, EPA and DHA in the intestine (
 <xref rid="B7" ref-type="bibr" class="xref">7</xref>), which prompted us to investigate mediator profiles by using LC-MS/MS analysis. We found that 17,18-EpETE was the metabolite whose levels increased the most in the gut of linseed oil-fed mice (
 <xref rid="B7" ref-type="bibr" class="xref">7</xref>). When 17,18-EpETE was intraperitoneally injected into soybean oil-fed mice, development of allergic diarrhea and degranulation of mast cells were inhibited, which was similar to observation in linseed oil-fed mice (
 <xref ref-type="fig" rid="F2" class="xref">Figure 2</xref>) (
 <xref rid="B7" ref-type="bibr" class="xref">7</xref>). Consistent with its action at the late stage of the allergic response, 17,18-EpETE was effective as a prophylactic and a therapeutic treatment for food allergy (
 <xref rid="B7" ref-type="bibr" class="xref">7</xref>).
</p>
